Opmop Ltd.

Israel

Back to Profile

1-3 of 3 for Opmop Ltd. Sort by
Query
Aggregations
Date
2026 (YTD) 1
Before 2021 2
IPC Class
A61K 36/734 - Crataegus (hawthorn) 1
A61K 36/8967 - Lilium, e.g. tiger lily or Easter lily 1
A61K 36/899 - Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane 1
A61K 38/00 - Medicinal preparations containing peptides 1
A61K 38/18 - Growth factorsGrowth regulators 1
See more
Found results for  patents

1.

METHODS OF MICROBIAL PROFILING

      
Application Number IL2025050563
Publication Number 2026/009222
Status In Force
Filing Date 2025-07-01
Publication Date 2026-01-08
Owner
  • YEDA RESEARCH AND DEVELOPMENT CO. LTD. (Israel)
  • OPMOP LTD (Israel)
Inventor
  • Reich, Ziv
  • Knafo, Maor
  • Rezenman, Shahar
  • Sade, Dagan
  • Shental, Noam

Abstract

Methods of profiling a microbial community within a biological niche comprising: receiving DNA extracted from samples from the niche, amplifying 16s rRNA genes from the samples to produce long amplicons, sequencing the long amplicons with long-read sequencing, generating a 16s rRNA database, amplifying and sequencing 16s rRNA genes from a sample using deep sequencing to produce reads and computationally combining the reads based on the database to produce full-length 16s rRNA sequences are provided. LNA primer pairs and kits comprising same are also provided.

IPC Classes  ?

2.

ERYTHROPOIETIN RECEPTOR ANTAGONISTS

      
Application Number IL2011000788
Publication Number 2012/046238
Status In Force
Filing Date 2011-10-06
Publication Date 2012-04-12
Owner
  • RAMOT AT TEL-AVIV UNIVERSITY LTD. (Israel)
  • OPMOP LTD. (Israel)
Inventor
  • Liron, Tamar
  • Souroujon, Miriam
  • Neumann, Drorit

Abstract

The present invention provides erythropoietin derived peptides which bind the erythropoietin receptor and inhibit EPO-induced cell proliferation. The invention further provides pharmaceutical compositions comprising same, and uses thereof in the treatment of primary and secondary erythrocytosis as well as for inhibiting undesirable cell proliferation induced by erythropoietin receptor in patients treated with erythropoietin.

IPC Classes  ?

3.

HERBAL COMPOSITION FOR PREVENTING AND\OR TREATING ANXIETY AND RELATED CONDITIONS

      
Application Number IL2011000221
Publication Number 2011/111039
Status In Force
Filing Date 2011-03-08
Publication Date 2011-09-15
Owner OPMOP LTD. (Israel)
Inventor
  • Doron, Ravid
  • Kately, Nadav

Abstract

The present invention relates to herbal compositions for the treatment and/or prevention of anxiety disorders or stress. These compositions comprise hawthorn fruit (Shan Zha), light wheat grain (Fu xiao mai( and Lilly Bulb (bai hi( in amounts which are effective to treat anxiety conditions. The compositions may further comprise Chinese date (Da zao(.

IPC Classes  ?